Validation and performance comparison of three SARS‐CoV‐2 antibody assays

Serology testing of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is increasingly being used during the current pandemic of coronavirus disease 2019 (COVID‐19), although its clinical and epidemiologic utilities are still debatable. Characterizing these assays provides scientific basis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2021-02, Vol.93 (2), p.916-923
Hauptverfasser:	Paiva, Kimberly J., Grisson, Ricky D., Chan, Philip A., Huard, Richard C., Caliendo, Angela M., Lonks, John R., King, Ewa, Tang, Eric W., Pytel‐Parenteau, Diane L., Nam, Ga H., Yakirevich, Evgeny, Lu, Shaolei
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies Antibodies, Viral - blood Assaying Chemiluminescence Coronaviridae Coronaviruses COVID-19 COVID-19 - diagnosis COVID-19 - immunology COVID-19 Serological Testing - methods Cross Reactions Epidemiology Female Hepatitis Humans Immunoassay - methods Immunoglobulin G Immunoglobulin G - blood Immunoglobulin M Immunoglobulin M - blood immunology Luminescent Measurements - methods Male Middle Aged Pandemics Public health Reagent Kits, Diagnostic SARS‐CoV‐2 Sensitivity Sensitivity and Specificity Serology Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Utilities Viral diseases Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!